DENVER--(BUSINESS WIRE)--Covidien (NYSE: COV, BSX: COV), a leading global provider of healthcare products, today announced the U.S. commercial availability of Covidien Imaging Solutions’ contrast delivery system with radio-frequency identification (RFID) technology. The components integrate RFID technology to create a system that is designed to aid in patient safety by helping to reduce the risk of medical errors in radiology departments.
